CD8A and cancer: Cognizant of the promise of using innate immune cells such as activated dendritic cells and NK cells in cancer therapy, several preclinical studies have been conducted, revealing that in the presence of pathogens, the dendritic cells secrete IFN1, which causes the activation of CD8+ Tc cells [61,62,63].